Sativex®: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2006-03-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656566.7.5.607PMID 16553576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Medicinal Uses of Cannabis and Cannabinoids

  2008cited by this paper
• Antidepressants for neuropathic pain.

  2007cited by this paper
• Smoked marijuana as a cause of lung injury.

  2005cited by this paper
• Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.

  2005cited by this paper
• Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis

  2005cited by this paper
• Pharmacological and therapeutic targets for Δ9 tetrahydrocannabinol and cannabidiol

  2004cited by this paper
• Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

  2004cited by this paper
• Effect of Δ-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults

  2004cited by this paper
• The medicinal use of cannabis in the UK: results of a nationwide survey

  2004cited by this paper
• Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial.

  2003cited by this paper
• A biomechanical investigation into the validity of the modified Ashworth Scale as a measure of elbow spasticity

  2003cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• Therapeutic aspects of cannabis and cannabinoids

  2001cited by this paper
• Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?

  2001cited by this paper
• Interferon in relapsing-remitting multiple sclerosis.

  2001cited by this paper
• Cannabinoid receptors and pain.

  2001cited by this paper
• A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity

  1999cited by this paper
• Cannabis as medicine: time for the phoenix to rise?

  1998cited by this paper
• Medical marijuana and its use by the immunocompromised.

  1997cited by this paper
• Pharmacology of cannabinoid CB1 and CB2 receptors.

  1997cited by this paper
• Medical marijuana and its use by the immunocompromised.

  1997cited by this paper
• Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol.

  1992cited by this paper
• Metabolites of cannabidiol identified in human urine.

  1990cited by this paper
• Disability, disease duration, and rehabilitation service needs in multiple sclerosis: patient perspectives.

  1986cited by this paper
• Excretion patterns of cannabinoid metabolites after last use in a group of chronic users

  1985cited by this paper

• Allodynia: Pathophysiology and emerging management strategies (Review)

  2026cites this paper
• Towards Enhanced Solubility of Cannabidiol: Preparation and Evaluation of Cannabidiol Solid Dispersions Using Vacuum Compression Molding

  2025cites this paper
• Clinical Management in Multiple Sclerosis

  2025cites this paper
• Cannabis consumption and motor vehicle collision: A systematic review and meta-analysis of observational studies.

  2025cites this paper
• Advances in the Quest for Safe and Effective Drugs That Target the Cannabinoid Receptor Type 1 (CB1).

  2025cites this paper
• Cannabinoids rescue migraine symptoms caused by central CGRP administration in mice

  2025cites this paper
• CANNABIS MEDICINAL E A DOR CRÔNICA

  2025cites this paper
• Transdermal Delivery of Cannabidiol for the Management of Acute Inflammatory Pain: A Comprehensive Review of the Literature

  2024cites this paper
• Development and Characterization of New Cannabidiol‐Loaded Polycaprolactone Nanoparticles for Increased Bioavailability

  2024cites this paper
• “The mushroom was more alive and vibrant”: Patient reports of synthetic versus organic forms of psilocybin

  2024cites this paper
• The Potential Role of Cannabidiol in Cosmetic Dermatology: A Literature Review

  2024cites this paper
• Cannabidiol-Based Prodrugs: Synthesis and Bioevaluation.

  2024cites this paper
• A comprehensive update on cannabidiol, its formulations and drug delivery systems

  2024cites this paper
• Asymmetric Synthesis of (-)-Cannabidiol (CBD), (-)-Δ9-Tetrahydrocannabinol (Δ9-THC) and Their cis Analogs Using an Enantioselective Organocatalyzed Diels-Alder Reaction.

  2024cites this paper
• The Minor Phytocannabinoid Delta-8-Tetrahydrocannabinol Attenuates Collagen-Induced Arthritic Inflammation and Pain-Depressed Behaviors

  2024cites this paper
• The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray.

  2024cites this paper
• Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use

  2024influential citation
• Exploring the versatile roles of the endocannabinoid system and phytocannabinoids in modulating bacterial infections

  2024cites this paper
• Cannabidiol treatment changes myocardial lipid profile in spontaneously hypertensive rats.

  2023cites this paper
• AN UPDATE OF NANO-BASED DRUG DELIVERY SYSTEMS FOR CANNABINOIDS: BIOPHARMACEUTICAL ASPECTS & THERAPEUTIC APPLICATIONS.

  2023cites this paper
• Extraction techniques for bioactive compounds of cannabis.

  2023cites this paper
• Screening System of Cannabis sativa Extracts Based on Their Mitochondrial Safety Profile Using Cytochrome c Oxidase Activity as a Biomarker

  2023cites this paper
• Exploring the Antibacterial Potential of Semisynthetic Phytocannabinoid: Tetrahydrocannabidiol (THCBD) as a Potential Antibacterial Agent against Sensitive and Resistant Strains of Staphylococcus aureus.

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 4

  2023cites this paper
• Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 2

  2023cites this paper
• Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids

  2023cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update—Surveillance Report 3

  2023cites this paper
• "Breaking bud": the effect of direct chemical modifications of phytocannabinoids on their bioavailability, physiological effects, and therapeutic potential.

  2023cites this paper
• Stereoselective Synthesis of Nonpsychotic Natural Cannabidiol and Its Unnatural/Terpenyl/Tail-Modified Analogues.

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2

  2022cites this paper
• Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 4

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 1, September 2022

  2022cites this paper
• Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy

  2022cites this paper
• Synthesis of the Cannabimovone and Cannabifuran Class of Minor Phytocannabinoids and Their Anti-inflammatory Activity.

  2022cites this paper
• Individual Approach in Achieving Optimal Balance of THC and CBD in Supplementary Treatment of Neurological Diseases

  2022cites this paper
• Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3

  2022cites this paper
• Title: Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?

  2021influential citation
• Title: Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?

  2021influential citation
• Investigation of Vaping Fluids Recovered From New York State E-Cigarette or Vaping Product Use-Associated Lung Injury Patients

  2021cites this paper
• The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases

  2021cites this paper
• Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice

  2021cites this paper
• Medicinal uses of Cannabis sp . Usos medicinais de Cannabis sp

  2021cites this paper
• The effects of cannabis and cannabinoids on the endocrine system

  2021cites this paper
• Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis

  2021cites this paper
• Delta-9-tetrahydrocannabinol and cannabidiol in psychosis: A balancing act of the principal phyto-cannabinoids on human brain and behavior?

  2021influential citation
• Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent

  2021cites this paper
• Delivering therapeutic cannabinoids via skin: Current state and future perspectives.

  2021cites this paper
• Practical Considerations of Hypotheses and Evidence in Cannabis Pharmacotherapy: Refining Expectations of Clinical Endocannabinoid Deficiency

  2020cites this paper
• The anti-inflammatory and analgesic effects of formulated full-spectrum cannabis extract in the treatment of neuropathic pain associated with multiple sclerosis

  2020cites this paper
• Cannabidiol-enriched hemp essential oil obtained by an optimized microwave-assisted extraction using a central composite design

  2020influential citation
• Protein Kinases Mediate Anti-Inflammatory Effects of Cannabidiol and Estradiol Against High Glucose in Cardiac Sodium Channels

  2020cites this paper
• Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity.

  2020cites this paper
• Source of cannabinoids: what is available, what is used, and where does it come from?

  2020cites this paper
• The molecular mechanisms that underpin the biological benefit of full spectrum cannabis extract in the treatment of neuropathic pain and inflammation.

  2020cites this paper
• Cannabidiol protects against high glucose‐induced oxidative stress and cytotoxicity in cardiac voltage‐gated sodium channels

  2020cites this paper
• The neuropharmacology of cannabinoid receptor ligands in central signaling pathways

  2020cites this paper
• USO DE CANABINOIDES COMO ADJUVANTE NO TRATAMENTO DA DOR CRÔNICA USE OF CANNABINOIDS AS ADJUVANT IN CHRONIC PAIN TREATMENT

  2019cites this paper
• Cannabis and cannabinoids on treatment of inflammation: a patent review.

  2019cites this paper
• Perioperative Management of the Pediatric Patient on Medicinal Marijuana: What Anesthesiologists Should Know.

  2019cites this paper
• Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort

  2018cites this paper
• Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

  2018cites this paper
• The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling

  2018cites this paper
• A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products

  2018cites this paper
• Cannabis Use as an Independent Risk Factor for, or Component Cause of, Schizophrenia and Related Psychotic Disorders

  2018cites this paper
• Diabetes and Cannabis: Myth or Reality

  2018cites this paper
• Effect of grape seed on quality of life in multiple sclerosis patients

  2018cites this paper
• Cannabinoids and Pain: Sites and Mechanisms of Action.

  2017cites this paper
• Neuroprotection by (Endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases

  2017cites this paper
• Pharmacology of cannabinoids in the treatment of epilepsy.

  2017cites this paper
• Maintenance of Blinding in Clinical Trials and the Implications for Studying Analgesia Using Cannabinoids

  2016cites this paper
• An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.

  2016cites this paper
• Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?

  2016cites this paper
• Is Tetrahydrocannabinol (THC)/Cannabidiol (CBD) Oromucosal Spray an Effective Adjuvant Therapy for Multiple Sclerosis Patients Who Suffer From Central Neuropathic Pain?

  2016influential citation
• Cannabis as a Possible Treatment for Spasticity in Multiple Sclerosis / Kanabis Kao Moguci Tretman U Lecenju Spasticnosti Kod Multiple Skleroze

  2016cites this paper
• Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation

  2016cites this paper
• Cannabidiol attenuates cardiac dysfunction , oxidative stress , fibrosis , and inflammatory and cell death signaling pathways in diabetic cardiomyopathy

  2016cites this paper
• Long‐Term Data of Efficacy, Safety, and Tolerability in a Real‐Life Setting of THC/CBD Oromucosal Spray‐Treated Multiple Sclerosis Patients

  2016cites this paper
• Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice

  2015cites this paper
• Cannabis-Derived Pharmaceuticals

  2015cites this paper
• "Disease modifying nutricals" for multiple sclerosis.

  2015cites this paper
• The Potential Impact of the Legalization and Decriminalization of Marijuana on the Vocational Rehabilitation Process. Why the Buzz?

  2015cites this paper
• Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects.

  2015cites this paper
• Prescrire du cannabis fumé pour la douleur chronique non cancéreuse: Recommandations préliminaires

  2014cites this paper
• Cannabinoids and the brain: New hopes for new therapies

  2014cites this paper
• Therapeutic Potential of Cannabinoids—Perspectives for the Future

  2014cites this paper
• Latest progress in the identification of novel synthetic ligands for the cannabinoid CB2 receptor.

  2014cites this paper
• Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations.

  2014cites this paper
• Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice

  2014cites this paper
• Aplicação de agonistas canabinoides na terapêutica e o seu impacto sociopolítico- económico

  2014cites this paper
• Personalized Management of Multiple Sclerosis

  2013cites this paper
• The role of complementary and alternative medicine in therapy of multiple sclerosis.

  2013cites this paper
• Low-dose vaporized cannabis significantly improves neuropathic pain.

  2013cites this paper
• Role of Cannabinoids in Pain Management

  2013cites this paper
• Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.

  2013cites this paper
• Complementary and alternative treatments

  2013cites this paper
• Cannabinoids.

  2013cites this paper
• Phytocannabinoids as novel therapeutic agents in CNS disorders.

  2012cites this paper
• Rehabilitation interventions in multiple sclerosis: an overview

  2012cites this paper